Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CATX | US
0
0%
Healthcare
Medical Devices
30/06/2024
08/04/2026
4.37
4.53
4.61
4.30
Perspective Therapeutics Inc. together with its subsidiaries develops manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate brain lung head and neck gynecological pelvic/abdominal and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray Inc. and changed its name to Perspective Therapeutics Inc. in February 2022. Perspective Therapeutics Inc. was founded in 1998 and is based in Richland Washington.
View LessValue Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Short percentage (> 15%)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
81.0%1 month
68.2%3 months
168.1%6 months
141.3%-
-
2.50
-
-
-21.91
68.73
-
-47.27M
294.66M
294.66M
-
-2.71K
-
-10.50
-23.20
8.97
17.32
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.80
Range1M
2.00
Range3M
3.91
Rel. volume
0.35
Price X volume
2.18M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| RxSight Inc. Common Stock | RXST | Medical Devices | 7.28 | 288.89M | 7.69% | n/a | 4.15% |
| Cellpoint Inc | CLPT | Medical Devices | 9.17 | 253.05M | 1.10% | n/a | 42.94% |
| 908 Devices Inc | MASS | Medical Devices | 7.03 | 243.64M | 3.99% | n/a | 3.58% |
| Harvard Bioscience Inc | HBIO | Medical Instruments & Supplies | 5.55 | 242.04M | 2.78% | n/a | 61.64% |
| OraSure Technologies Inc | OSUR | Medical Instruments & Supplies | 3.08 | 229.67M | 0.65% | 11.53 | 2.96% |
| Utah Medical Products Inc | UTMD | Medical Instruments & Supplies | 64.53 | 224.38M | 1.67% | 15.31 | 0.22% |
| BRAINSWAY LTD | BWAY | Medical Devices | 13.23 | 220.65M | 7.91% | 503.00 | 10.16% |
| Outset Medical Inc | OM | Medical Devices | 4.2 | 218.78M | 2.44% | n/a | 294.91% |
| Electromed Inc | ELMD | Medical Devices | 24.4 | 205.08M | 2.61% | 39.79 | 0.20% |
| InfuSystem Holdings Inc | INFU | Medical Instruments & Supplies | 9.47 | 201.86M | 1.18% | 702.00 | 73.21% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 2.91 | 278.77M | 2.46% | n/a | 174.23% |
| Urban One Inc | UONEK | Broadcasting - Radio | 5.23 | 277.23M | n/a | 268.43% | |
| The RMR Group Inc | RMR | Real Estate Services | 16.12 | 269.60M | 1.96% | 16.64 | 14.14% |
| Comstock Holding Companies Inc | CHCI | Real Estate Services | 18.86 | 185.99M | 0.05% | 14.10 | 17.12% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 16.56 | 184.77M | 1.41% | 15.61 | -621.78% |
| RE/MAX Holdings Inc | RMAX | Real Estate Services | 5.81 | 182.53M | 1.22% | n/a | 114.28% |
| Douglas Elliman Inc. | DOUG | Real Estate Services | 1.69 | 155.20M | 5.63% | n/a | 62.82% |
| STHO | STHO | Real Estate Services | 8.09 | 107.76M | 1.38% | n/a | 59.21% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.71 | 99.68M | 5.16 | 19.82% | |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 5.68 | 92.52M | -5.33% | 9.09 | 39.79% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -21.91 | 46.09 | Cheaper |
| Ent. to Revenue | 68.73 | 14.34 | Expensive |
| PE Ratio | - | 30.41 | - |
| Price to Book | 2.50 | 6.21 | Cheaper |
| Dividend Yield | - | 1.78 | - |
| Std. Deviation (3M) | 168.13 | 64.12 | Riskier |
| Debt to Equity | - | -145.53 | - |
| Debt to Assets | - | 0.35 | - |
| Market Cap | 294.66M | 9.70B | Emerging |